Edition:
United States

Myriad Genetics Inc (MYGN.OQ)

MYGN.OQ on NASDAQ Stock Exchange Global Select Market

42.82USD
4:00pm EDT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$42.82
Open
$42.84
Day's High
$42.95
Day's Low
$42.43
Volume
139,004
Avg. Vol
280,429
52-wk High
$44.31
52-wk Low
$23.34

Chart for

About

Myriad Genetics, Inc. is a molecular diagnostic company. The Company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. The Company operates through two segments: diagnostics and other. The diagnostics segment provides testing and collaborative development of testing that is... (more)

Overall

Beta: 0.48
Market Cap(Mil.): $2,993.41
Shares Outstanding(Mil.): 69.91
Dividend: --
Yield (%): --

Financials

  MYGN.OQ Industry Sector
P/E (TTM): 28.81 37.27 32.89
EPS (TTM): 1.49 -- --
ROI: 9.63 8.77 13.14
ROE: 12.35 12.58 15.15

BRIEF-Myriad Genetics Reports Q3 GAAP Earnings Per Share $0.16

* MYRIAD GENETICS REPORTS FISCAL THIRD-QUARTER 2018 FINANCIAL RESULTS

May 08 2018

BRIEF-Myriad Receives Pre Market Approval For Its Bracanalysis Diagnostic System In Japan

April 2 Myriad Genetics Inc - ‍Astrazeneca And Merck Are Seeking Approval Of Lynparza In Japan For Treating Patients With Brca :

Apr 02 2018

BRIEF-Myriad Genetics Q2 Adjusted Earnings Per Share $0.31

* MYRIAD GENETICS REPORTS FISCAL SECOND-QUARTER 2018 FINANCIAL RESULTS

Feb 06 2018

Earnings vs. Estimates